The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

Scientists at the University of Lausanne (UNIL) and University center Unisanté classified 35 commonly used drugs in Switzerland based on their impact on the aquatic biodiversity. Scientists at the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

President Trump recently signed an executive order changing marijuana’s Controlled Substances Act classification from ...

Cannabis may be on its way to being less restricted in the U.S. after a recent recommendation from the Health and Human Services Department to reschedule the drug's classification. Last week, the HHS ...

President Trump is expected to sign an order that would reschedule marijuana to a lower drug classification, according to two sources, in one of the most significant changes to drug policy in decades.

Researchers have turned the spotlight on a new class of drugs that they say could “transform” the field of medicine – and the drugs work by targeting aging. The researchers, from the Mayo Clinic in ...

Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same ...